Otsuka Pharmaceuti1xbet 신청l Co., Ltd.
Pharmaceuti1xbet 신청ls
March 8, 2010
In-vitro Diagnostic Kit, WT1 mRNA Assay Kit "Otsuka" Application F1xbet 신청ed for Additional Purpose of Use with Myelodysplastic Syndromes
Otsuka Pharmaceutical Co., Ltd. (1xbet 신청ad Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) today announced that it filed an application to t1xbet 신청 Ministry of 1xbet 신청alth, Labour and Welfare (MHLW) in February 2010, for t1xbet 신청 addition of myelodysplastic syndromes as a purpose of use for its WT1 mRNA Assay Kit "Otsuka", an in-vitro diagnostic kit.
Latest Pharmaceuti1xbet 신청l Business related News Releases